SAN DIEGO — Oxiris membranes may offer no clinical advantage vs. standard membranes to maintain hemodynamic stability in patients with septic shock who need continuous kidney replacement therapy, data presented at ASN Kidney Week show.
We’re sorry, but an unexpected error has occurred.
Please refresh your browser and try again. If this error persists, please contact ITSupport@wyanokegroup.com for assistance.
Would you like to receive email reminders to complete your saved activities from Healio CME?
Activity saved! You'll receive reminders to complete your saved activities from Healio CME.